FDA clears Pathway Medical peripheral atherectomy system

TriMed Staff | | Health Imaging | Diagnostic Imaging

Pathway Medical Technologies has been granted FDA 510(k) approval to sell its Pathway PV Atherectomy system, which cuts and removes plaque from leg arteries.

The Kirkland, Wash.-based company said its system has expandable, rotating scraping blades with aspiration for preemptive removal of both hard and soft plaque. The device treats peripheral artery disease, which afflicts about 8 million people, according to the American Heart Association (AHA).

Pathway plans to recruit a sales force and build inventory before taking the product to market, said Stephanie Amoss, vice president of marketing.

The company hopes to assemble an initial sales force of 15 to 25 people to begin selling the device in the fourth quarter of this year.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.